Clodazon

This classification denotes an antidepressant agent with the molecular formula C18H20ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X82H6JOC4H, chemically known as 2h-benzimidazol-2-one, 5-chloro-1-(3-(dimethylamino)propyl)-1,3-dihydro-3-phenyl- (9ci) but generally known as clodazon, which bears US NIH Compound Identifier 20883. European Medicines Agency schedules Clodazon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06691MIG. The term CLODAZON is an International Non-Proprietary Name. CLODAZON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clodazon under HS 29339990 and SITC 51577. As of Q4 2014, CLODAZON remains the US FDA Preferred Term for this commodity. Clodazon bears US NLM identifiers UMLS ID C2699359 and NCI Concept Code C78011. SMILES: Clc1cc2n(c(=O)n(CCCN(C)C)c2cc1)c1ccccc1.